Concourse Financial Group Securities’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Hold |
0
| – | – | – | 10259 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 10022 |
|
2023
Q3 | – | Hold |
0
| – | – | – | 9775 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 9554 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 9194 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 9203 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 9007 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 8837 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 8633 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 8325 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 7874 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 7504 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 7174 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 6880 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 6622 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 6457 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 6351 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 6267 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 6114 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 6102 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 5975 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 5888 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 5737 |
|